Author:
DURHAM W.J.,WEHRENS X.H.T.,SOOD S.,HAMILTON S.L.
Reference248 articles.
1. (1984). “A Protocol for the Investigation of Malignant Hyperpyrexia (MH) Susceptibility. The European Malignant Hyperpyrexia Group.” Br J Anaesth 56(11): 1267–9.
2. Aizawa, Y., Ueda, K., Komura, S., Washizuka, T., Chinushi, M., Inagaki, N., Matsumoto, Y., Hayashi,T. and M. Takahashi, Nakano, N., Yasunami, M., Kimura, A., and Hiraoka, M. (2005). “A Novel Mutation in FKBP12.6 Binding Region of the Human Cardiac Ryanodine Receptor Gene (R2401H) in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia.” Int J Cardiol 99(2): 343–5.
3. Apkon, M. (2003). Cellular Physiology of Skeletal, Cardiac, and Smooth Muscle. Medical Physiology: A Cellular and Molecular Approach. W. Boron, Boulpaep. Philadephia, Saunders: 230–254.
4. Avila, G.,and Dirksen, R. T. (2001a). “Functional Effects of Central Core Disease Mutations in the Cytoplasmic Region of the Skeletal Muscle Ryanodine Receptor.” J Gen Physiol 118(3): 277–90.
5. Avila, G., O’Brien, J. J., and Dirksen, R. T. (2001b). “Excitation-Contraction Uncoupling by a Human Central Core Disease Mutation in the Ryanodine Receptor.” Proc Natl Acad Sci U S A 98(7): 4215–20.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献